By Mill Chart
Last update: Mar 28, 2025
For growth-minded investors, high revenue and EPS growth are key criteria. Today, we'll examine whether HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) fits the bill for growth investing, particularly as it forms a base and hints at a potential breakout. Remember, due diligence is essential, but HARMONY BIOSCIENCES HOLDINGS has caught our attention on our screen for growth with base formation. It may warrant additional investigation.
To evaluate a stock's growth potential, ChartMill utilizes a Growth Rating on a scale of 0 to 10. This comprehensive assessment considers various growth aspects, including historical and estimated EPS and revenue growth. HRMY has achieved a 9 out of 10:
ChartMill assigns a proprietary Health Rating to each stock. The score is computed by evaluating various liquidity and solvency ratios and ranges from 0 to 10. HRMY was assigned a score of 8 for health:
ChartMill employs its own Profitability Rating system for stock evaluation. This score, ranging from 0 to 10, is derived from an analysis of diverse profitability metrics and margins. In the case of HRMY, the assigned 8 is noteworthy for profitability:
ChartMill also assigns a Setup Rating to each stock. This rating, on a scale of 0 to 10, reflects the degree of consolidation observed based on short-term technical indicators. Currently, HRMY exhibits a 8 setup rating, indicating its consolidation status in recent days and weeks.
Although the technical rating is bad, HRMY does present a nice setup opportunity. We see reduced volatility while prices have been consolidating in the most recent period. There is a support zone below the current price at 32.53, a Stop Loss order could be placed below this zone.
Our Strong Growth screener lists more Strong Growth stocks and is updated daily.
Check the latest full fundamental report of HRMY for a complete fundamental analysis.
For an up to date full technical analysis you can check the technical report of HRMY
Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.
28.46
+0.52 (+1.86%)
Find more stocks in the Stock Screener
Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
HARMONY BIOSCIENCES HOLDINGS was identified as a growth stock that isn't overvalued. NASDAQ:HRMY is excelling in various growth indicators while maintaining a solid financial footing.